The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

This study is about finding better ways to help people living with major depression, especially when their first treatment hasn't worked as well as hoped. Major depression is a common illness that can make everyday life very difficult. While there are many antidepressant medications available, finding the right one can sometimes be a process of trial and error. This means that a treatment that works for one person might not work for another.

Recently, a new nasal spray called esketamine has become available for people whose depression has been particularly difficult to treat, even after trying several other medications. This study wants to see if using esketamine more intensively, or even earlier in the treatment journey, could make a big difference. Researchers are particularly interested in whether this approach could prevent depression from becoming resistant to treatment, which happens when two or more different antidepressants haven't helped enough.

By comparing this intensified treatment to the usual care, the study aims to understand if we can help people get better sooner and avoid unnecessary trials of different medications. This could improve people's quality of life, reduce the difficulties they face, and potentially lower the overall costs of healthcare related to long-term depression. It's a chance to explore new strategies to help those who are really struggling.